STOPP-START Medication Review: A Non-Randomized Trial in an Indonesian Tertiary Hospital to Improve Medication Appropriateness and to Reduce the Length of Stay of Older Adults
Restricted accessResearch articleFirst published online December, 2021
STOPP-START Medication Review: A Non-Randomized Trial in an Indonesian Tertiary Hospital to Improve Medication Appropriateness and to Reduce the Length of Stay of Older Adults
Background: Inappropriate prescribing may lead to medication errors among older adults. Pharmacists can curb the occurrences of these errors by conducting medication reviews. Screening Tool of Older Person’s Prescriptions (STOPP) or Screening Tool to Alert doctors to Right Treatments (START) may curb the incidence of adverse drug reactions and improve medication appropriateness by providing guides about when particular types of medications should be started or stopped. Objective: This study aimed to evaluate the use of STOPP/START to improve the Adapted Medication Appropriateness Index (MAI), to reduce the risk of ADRs (GerontoNet score), and length of stay (LOS). Setting: Geriatric Inpatient Ward, Sanglah General Hospital, Bali, Indonesia. Method: A non-randomized controlled trial was conducted in older adults (>60 years) who were selected consecutively from inpatient units in a tertiary hospital in Bali, Indonesia. The intervention group received medication reviews by pharmacists in collaboration with physicians to assess its appropriateness with STOPP/START criteria on admission and during their stay at the hospital. The control group obtained standard care. Main Outcome Measures: The outcomes were measured using the Adapted MAI, GerontoNet Score, and LOS. Results: Thirty patients in the intervention group and 33 patients in the control group were included in this study. The adapted MAI was 2.97 (2.25) and 9.94 (6.14) with P < .001. The GerontoNet score was 3.33 (2.28) and 5.18 (2.10) with P = .003, LOS was 7.63 (3.00) days and 14.18 (9.97) days with P = .011, respectively. Conclusion: The use of STOPP/START as a tool for medication review improved medication appropriateness and reduced ADR risk and LOS.
HalterJBOuslanderJGTinettiMEStudenskiSHighKPAsthanaS, eds. Hazzard’s Geriatric Medicine and Gerontology. 6th ed.Washington, DC: McGraw-Hill Companies, Inc.; 2009.
4.
RahmawatiFNurrochmahHWasilahRSulaimanSAS. Potentiality of drug-drug interaction in hospitalized geriatric patients in a private hospital, Yogyakarta, Indonesia. Asian J Pharm Clin Res. 2010;3(3):191-194.
5.
KulkarniVBoraSSSirishaSSajiMSundaranS.A study on drug–drug interactions through prescription analysis in a South Indian teaching hospital. Ther Adv Drug Saf. 2013;4(4):141-146. doi:10.1177/2042098613490009
6.
BucşaaCFarcaşaACazacuaI, et al. How many potential drug–drug interactions cause adverse drug reactions in hospitalized patients?. Eur J Intern Med. 2013;24(1):27-33.
7.
DumbreckSFlynnANairnM, et al. Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ. 2015;350:h949. doi:10.1136/bmj.h949
8.
ShahBMHajjarER.Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med. 2012;28:173-186. doi:10.1016/j.cger.2012.01.002
9.
TekaFTeklayGAyalewETeshomeT.Potential drug–drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: a cross sectional study. BMC Res Notes. 2016;9(1):431. doi:10.1186/s13104-016-2238-5
10.
KeersRNWilliamsSDCookeJAshcroftDM.Causes of medication administration errors in hospitals: a systematic review of quantitative and qualitative evidence. Drug Saf. 2013;36(11):1045-1067. doi:10.1007/s40264-013-0090-2
11.
TariqRAScherbakY.Medication errors. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2019. Accessed May 25, 2020. https://www.ncbi.nlm.nih.gov/books/NBK519065/
12.
WheelerAJScahillSHopcroftDStapletonH.Reducing medication errors at transitions of care is everyone’s business. Aust Prescr. 2018;41(3):73-77.
da SilvaBAKrishnamurthyM.The alarming reality of medication error: a patient case and review of Pennsylvania and National data. J Community Hosp Intern Med Perspect. 2016;6(4):31758. doi:10.3402/jchimp.v6.31758
15.
LavanAHGallagherPFO’MahonyD.Methods to reduce prescribing errors in elderly patients with multimorbidity. Clin Interv Aging. 2016;11:857-866. doi:10.2147/CIA.S80280
16.
ChristensenMLundhA.Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2016;2:CD008986. doi:10.1002/14651858.CD008986.pub3
17.
KianmehrNMofidiMSaidiHHajibeigiMRezaiM.What are patients’ concerns about medical errors in an Emergency Department?. Sultan Qaboos Univ Med J. 2012;12(1):86-92.
18.
BahraniLErikssonTHöglundPMidlövP.The rate and nature of medication errors among elderly upon admission to hospital after implementation of clinical pharmacist-led medication reconciliation. Eur J Hosp Pharm. 2014;21(3): 156-160.
19.
PepaPALangley-DeGrootMHRuleOS.Prescribing cascade in a geropsychiatric patient: a slippery slope. J Geriatr Ment Health. 2018;5(1):62-64. doi:10.4103/jgmh.jgmh_17_17
20.
MorimotoTGandhiTKSegerACHsiehTCBatesDW.Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004;13(4):306-314.
21.
KlopotowskaJEWierengaPCStuijtCCM, et al. Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy. PLoS ONE. 2013;8(8):e71045. doi:10.1371/journal.pone.0071045
22.
NachtigallAHeppnerHJThürmannPA.Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial. Ther Adv Drug Saf. 2019;10:2042098619843365. doi:10.1177/2042098619843365
23.
RollasonVVogtN.Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging. 2003;20(11):817-832. doi:10.2165/00002512-200320110-00003
24.
HailuBYBerheDFGudinaEKGideyKGetachewM.Drug related problems in admitted geriatric patients: the impact of clinical pharmacist interventions. BMC Geriatr. 2020;20(13):1-8. doi:10.1186/s12877-020-1413-7
25.
GallagherPFO’MahonyD.STOPP (Screening Tool of Older Persons potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers criteria. Age Ageing. 2008;37(6):673-679.
26.
O’MahonyDO’SullivanDByrneSO’ConnorMNRyanCGallagherP.STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213-218. doi:10.1093/ageing/afu145
27.
VaralloFRCapuchoHCPlanetaCSMastroianniPC.Safety assessment of potentially inappropriate medications (PIM) use in older people and the factors associated with hospital admission. J Pharm Pharmaceu Sci. 2011;14(2):283-290.
28.
FickDMCooperJWWadeWEWallerJLMacleanJRBeersMH.Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716-2724.
29.
MeulendijkMCSpruitMRDrenth-van MaanenAC, et al. Computerized decision support improves medication review effectiveness: an experiment evaluating the STRIP assistant’s usability. Drugs Aging. 2015;32(6):495-503. doi:10.1007/s40266-015-0270-0
30.
GallagherPFO’ConnorMNO’MahonyD.Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89(6):845-854.
31.
ChangCBChenJHWenCJ, et al. Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria. Brit J Clin Pharmacol. 2011;72(3):482-489.
32.
ParkerKBull-EngelstadIBenthJŠ, et al. Effectiveness of using STOPP/START criteria to identify potentially inappropriate medication in people aged ≥ 65 years with chronic kidney disease: a randomized clinical trial. Eur J Clin Pharmacol. 2019;75(11):1503-1511. doi:10.1007/s00228-019-02727-9
33.
MekdadSSAlsayedAA.Quality Improvement project to reduce drug-related problems (DRPs) and potentially inappropriate medications (PIMs) in Geriatrics Cardiac Clinic in Saudi Arabia. Can Geriatr J. 2019;22(2):49-54. doi:10.5770/cgj.22.338
34.
WilliamsSMillerGKhouryRGrossbergGT.Rational deprescribing in the elderly. Ann Clin Psychiatry. 2019;31(2):144-152.
35.
UmıtEGBaysalMBasVAskerIKırkızlarODemırAM.Polypharmacy and potentially inappropriate medication use in older patients with multiple myeloma, related to fall risk and autonomous neuropathy. J Oncol Pharm Pract. 2019;26(1):43-50. doi:10.1177/1078155219835303
36.
SiripalaUGSPremadasaSPKSamaranayakeNRWanigatungeCA. Usefulness of STOPP/START criteria to assess appropriateness of medicines prescribed to older adults in a resource-limited setting. Int J Clin Pharm. 2019;41(2):525-530. doi:10.1007/s11096-019-00786-7
37.
Hill-TaylorBWalshKAStewartSHaydenJByrneSSketrisIS.Effectiveness of the STOPP/START (Screening Tool of Older Persons’ potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther. 2016;41(2):158-169. doi:10.1111/jcpt.12372
38.
JulaihaS.Identifikasi potentially inappropriate medications (PIMs) berdasarkan kriteria STOPP START pada pasien geriatri rawat inap di RS Advent Bandar Lampung. Jurnal Analis Kesehatan. 2018;7(1):657-665.
39.
FitriahN.Analisis penggunaan obat pada pasien geriatri Rawat Jalan Poli Jantung RSD Dr. Soebandi Jember dengan Metode STOPP START [undergraduate theses]. Jember: Universitas Jember; 2018.
40.
Pharmaceutical Care Network Europe. Statement on Medication Review 2013. Zuidlaren: PCNE; 2013.
41.
GallagherPFRyanCByrneSKennedyJO’MahonyD.STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72-83.
42.
O’ConnorMNGallagherPO’MahonyD.Inappropriate prescribing criteria, detection and prevention. Drugs Aging. 2012;29(6):437-452.
43.
WhiteheadALJuliousSACooperCLCampbellMJ.Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016;25(3):1057-1073.
44.
HanlonJTSchmaderKE.The medication appropriateness index at 20: where it started, where it has been, and where it may be going. Drugs Aging. 2013;30(11):893-900. doi:10.1007/s40266-013-0118-4
45.
NairNPChalmersLPetersonGMBereznickiBJCastelinoRLBereznickiLR.Hospitalization in older patients due to adverse drug reactions—the need for a prediction tool. Clin Interv Aging. 2016; 11:497-505.
46.
OnderGPetrovicMTangiisuranB, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older. Arch Intern Med. 2010;170(13):1142-1148.
47.
PageRL2ndLinneburSABryantLLRuscinJM.Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75-87.
48.
TokudaY.Polypharmacy, inappropriate prescribing and adverse drug events in Japan. J Gen Fam Med. 2016;17(1):3-4.
49.
PérezTMoriartyFWallaceEMcDowellRRedmondPFaheyT.Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study. BMJ. 2018;363:k4524. doi:10.1136/bmj.k4524
50.
SilvaROSMacêdoLASantosGADJrAguiarPMde LyraDPJr.Pharmacist-participated medication review in different practice settings: service or intervention? An overview of systematic reviews. PLoS ONE. 2019;14(1):e0210312. doi:10.1371/journal.pone.0210312
51.
GeurtsMMTalsmaJBrouwersJRde GierJJ.Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol. 2012;74(1):16-33. doi:10.1111/j.1365-2125.2012.04178.x
BaekHChoMKimSHwangHSongMYooS.Analysis of length of hospital stay using electronic health records: a statistical and data mining approach. PLoS ONE. 2018;13(4):e0195901. doi:10.1371/journal.pone.0195901
54.
VetranoDLLandiFDe BuyserSL, et al. Predictors of length of hospital stay among older adults admitted to acute care wards: a multicentre observational study. Eur J Intern Med. 2014;25:56-62.
55.
BaileyJGDavisPJLevyARMolinariMJohnsonPM.The impact of adverse events on health care costs for older adults undergoing nonelective abdominal surgery. Can J Surg. 2016;59(3):172-179. doi:10.1503/cjs.013915
56.
BarnesDEPalmerRMKresevicDM, et al. Acute care for elders units produced shorter hospital stays at lower cost while maintaining patients’ functional status. Health Aff (Millwood). 2012;31(6):1227-1236. doi:10.1377/hlthaff.2012.0142
57.
Calderón-LarrañagaAPoblador-PlouBGonzález-RubioFGimeno-FeliuLAAbad-DíezJAPrados-TorresA.Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?. Br J Gen Pract. 2012;62(605): e821-e826. doi:10.3399/bjgp12X659295
58.
FrancisJAbrahamS.Clinical pharmacists: bridging the gap between patients and physicians. Saudi Pharm J. 2014; 22(6):600-602. doi:10.1016/j.jsps.2014.02.011
59.
TsakitzidisGTimmermansOCallewaertN, et al. Outcome indicators on interprofessional collaboration interventions for elderly. Int J Integr Care. 2016;16(2):5.
60.
MathiesonK.Making sense of biostatistics: types of nonprobability sampling. J Clin Res Best Pract. 2014;10(10):1-2.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
